semaglutide and herpes Association of GLP-1 receptor agonists with risks in diabetes mellitus: a target trial emulation Semaglutide's Alzheimer's Trial Failure: Rethinking

In 1997, the FDA pulled fenfluramine and dexfenfluramine off the market, marking the beginning of a merry-go-round of regulatory rejections, approvals, and withdrawals for weight-loss drugs

The role of other medications and supplements Many semaglutide users take other medications or supplements concurrently, and some of these can independently affect UTI risk

Hormonal biology was a footnote, not a design input

Regular monitoring of kidney function is essential, as both metformin and GLP-1 agonists require adequate renal clearance

This can potentially increase the risk of pulmonary aspiration during sedation if gastric contents are retained despite standard fasting periods, though this risk varies significantly among individuals

It helps neutralize harmful free radicals and toxins, supports tissue repair, and promotes overall cellular detoxification and redox balance